Nexstim Plc announced having received an NBS System 6 order from a hospital in Massachusetts, United States. Nexstim released the NBS 6 in the spring of 2023 and announced first order for the system on November 14. The NBS System 6 is a new generation system that makes Nexstim?s established TMS technology even more intuitive to use and allows for an expansion of system capabilities over time.

Currently FDA approved for the treatment of major depressive disorder (MDD), the system has been created to answer to the needs of Nexstim?s current and potential customers.